Cantor Fitzgerald Reiterates Overweight on Zosano Pharma, Lowers Price Target to $6

Cantor Fitzgerald reiterates Zosano Pharma (NASDAQ:ZSAN) with a Overweight and lowers the price target from $12 to $6.

Benzinga · 11/15/2019 12:28

Cantor Fitzgerald reiterates Zosano Pharma (NASDAQ:ZSAN) with a Overweight and lowers the price target from $12 to $6.